Biomarker Congress Europe 2027

The European choice

Choosing your biomarker congress Europe 2027 budget line

Most EU-headquartered diagnostics and tools companies can fund one biomarker congress Europe 2027 slot with real commitment behind it, so the question is which room gives your team the most qualified buyers per day away from the office.

If you are based in Germany, Switzerland, the Netherlands, the Nordics or France, or expanding into Europe, ImmunoMark London is built for that decision. The 2nd annual UK edition runs on 3–4 March 2027 with a target of 400+ delegates. It is held in London but draws from across the continent: four in ten delegates come from outside the UK and Ireland.

40%of delegates from the rest of Europe

60%from the UK & Ireland

55–60%from biotech and pharma

45–50%senior leadership

The continental presence shows up on stage and on the exhibition floor. In 2026 speakers came from KU Leuven, the Istituto Nazionale Tumori IRCCS Pascale in Naples, CNRS and the National Research Council of Italy, and vendors included Hologic Diagenode’s EMEA business development team, Secretech’s Business Development Manager Europe and PromoCell. The 2027 speaker panel includes Petri Bono of Faron Pharmaceuticals (Helsinki), Marc Siggel of Merck KGaA (Darmstadt) and Alexander Eggermont of OncIntel B.V.

The programme is oncology-only. Unlike a general biomarkers congress that covers every therapeutic area, both ImmunoMark streams stay in cancer: Next-Gen Immuno-Oncology and Biomarkers & Companion Diagnostics. In practice it is a tumour biomarker conference, UK-hosted, with a European delegate base.

Comparison

How to compare biomarker conferences 2027 Europe-wide

Use these criteria to compare any biomarker conference on your shortlist. The right-hand column shows what ImmunoMark London offers on each.

What to check	Why it matters for an EU vendor	ImmunoMark London 2027
Delegate geography	You need buyers from several markets, not only the host city	60% UK & Ireland, 40% rest of Europe
Seniority	Travel cost is only justified if budget holders are present	45–50% senior leadership; 70% senior decision-makers at London 2026
Therapeutic focus	Broad events spread your buyers across disease areas	Oncology only, with a dedicated Biomarkers & CDx stream
Meeting mechanics	A small team flying in needs a booked diary	Pre-arranged 20-minute 1:1s chosen from full delegate profiles sent 10 days before
Timing	Early-year events let you build pipeline for the rest of the year	A biomarker conference March 2027 slot: 3–4 March
Regulatory content	Your buyers work under IVDR in the EU and MHRA rules in Great Britain	Day 2 panel: Global CDx Approval Pathways – EMA, FDA & MHRA Perspectives
Track record	Evidence that sponsors actually get meetings	200+ meetings in 2026; 15–25 meetings per sponsor

Our guide on how to choose biotech conferences to sponsor goes further into scoring events before you commit budget.

IVDR-era buyers

Selling to buyers working across IVDR, MHRA and FDA rules

Since the UK left the EU, a pharma team running a European oncology programme deals with at least two diagnostic regimes: the EU In Vitro Diagnostic Regulation and the MHRA framework in Great Britain. Many also plan for FDA. Vendors who can talk about all three are easier to buy from.

EU buyers

Their questions are about IVDR evidence, notified bodies and what your assay documentation will support. Session: Regulation of Companion Diagnostics from a Pharma Perspective (Day 1).

UK buyers

They need to know how a test reaches the British market under MHRA rules. Session: Panel: Global CDx Approval Pathways – EMA, FDA & MHRA Perspectives (Day 2).

Global programme leads

They want one partner across regions and a route to qualification. Session: Panel: Regulatory Harmonisation for Biomarker Qualification (Day 1).

Commercial questions follow regulatory ones. The Day 2 session on Companion Diagnostics Commercialisation & Reimbursement Strategy is where market-access and diagnostics leads compare notes on getting a test paid for across European systems.

Packages

Which package works for a European vendor

If London is your one European biomarker event, pre-event reach matters as much as the two days themselves: continental delegates plan their schedules before they travel.

Best fit

Platinum (Stream 2)

The package with pre-event reach built in. Your email campaign and 1-minute video reach delegates before they book their days, and the attendee list arrives a week early so you can plan across UK and EU accounts.

Email campaign to attendees and 1-minute video promotion
Attendee list a week before
10 pre-scheduled 1:1 meetings
30-minute Day 1 talk; 10 x 6 ft booth
8 + 8 passes

Exclusive 1:1 Meetings

For teams who want to test London before a larger commitment. No booth to build or ship, just a booked diary.

7 or 10 meetings of 20 minutes
4 passes plus drinks reception passes
Logo and description in brochure and webpage
Wishlist and delegate list

Exhibitor

For companies who need a physical presence for demos and want the delegate list for their European sales team.

10 x 6 ft booth with table, 2 chairs and power
2 + 2 passes
Delegate list and wishlist
Website and brochure logo

The ROI calculator below helps you check the business case against your own deal size. Full package details are on the London sponsorship opportunities page.

Europe and the US

Pairing London with a US edition

One 2026 sponsor that provides assays in both Europe and the US told us it was considering coupling the two. ImmunoMark runs a launch edition in San Diego on 10–11 February 2027 and a launch edition in Boston in June 2027, with the same package structure at every edition. The biomarker conference series page compares San Diego, London and Boston for a biomarker sponsor.

If your product is a companion diagnostic or you advise on IVDR and MHRA submissions, the companion diagnostics conference London page is written for you. For a fuller picture of the London Stream 2 audience by buyer role, see the biomarker conference London overview.

Tell us where your team is based and which markets you sell into, and we will suggest a London plan.

Request the prospectus

Sponsorship ROI calculator

What could London 2027 be worth to your team?

Pick a package, add your own numbers and see the pipeline it creates. London 2026 sponsors averaged 15 to 25 meetings each, with 70% senior decision-makers in the room.

1. Choose a package

Sponsorship packages

Exclusive 1:1 meeting packages

2. Your numbers

Average first-year deal value

Year-one value of a new pharma or biotech customer

Extra conversations at the event

Booth visits, networking and questions after your talk

Become a real opportunity

Share of conversations worth a proposal

Opportunities you usually win

Your typical close rate

Your total event budget

Sponsorship plus travel and team costs

Estimated return

expected first-year revenue for every £1 of your event budget

Pre-scheduled 1:1 meetings

Qualified conversations

New opportunities

Cost per conversation

Pipeline created

Expected revenue won

Get pricing and the prospectus for this package Or talk to our team about a custom package

Estimates only, based on the numbers you enter. Meetings and inclusions from the London 2027 sponsorship prospectus. 1:1 meetings are pre-scheduled with delegates you choose from the attendee list.

What sponsors said

Feedback from London 2026 sponsors

Here is what sponsors told us at our London 2026 launch edition.

We really liked the focus of the event, the topics, the talks, really good opportunity to engage with people, the support we get from you is really great and we appreciate that very much. Based on our experience we would be very interested in also sponsoring the next annual event.

Project Manager

PromoCell GmbH · Sponsor, London 2026

We are always interested in sponsoring interesting conference, based on this years experience, I guess I will manage to get some budget for the next edition.

BD Manager Europe

Secretech · Sponsor, London 2026

Conversations I have had are very high level, the footfalls been great and the kind of research going on around is really life changing. We will be very interested in sponsoring the second annual.

Research Account Manager

Miltenyi Biotec · Sponsor, London 2026

My experience here at Immunomark 2026 has been really great. We benefit from very good logistical organisation. Networking sessions were excellent and we consider Immunomark a strategic conference for the coming years.

Senior Business Development Director Europe

Rouken Bio · Sponsor, London 2026

We got the occasion to discuss customer projects and understand their needs better and how we can help them.

Epigenomics Applications Specialist

Hologic Diagenode · Sponsor, London 2026

The conference has been great so far with strong interactions at the booth and excellent attendance at our talk. We will definitely think about the next edition.

Biopharma Business Development Manager EMEA

Hologic Diagenode · Sponsor, London 2026

Quality of the talks were really nice and the attendee list had experts from biotech pharma field. It was great meeting everyone and we look forward to positive outcomes.

Business Development Executive

HistologiX · Sponsor, London 2026

The talks have been really interesting so far with a great combination of researchers and clinicians. Moderators encouraged excellent discussions.

Product Specialist

HAWK Biosystems · Sponsor, London 2026

Get the prospectus

Frequently asked questions

How European is the London audience?

Delegate geography for ImmunoMark London is 60% UK & Ireland and 40% rest of Europe. In 2026 speakers and vendors included organisations from Belgium, Italy, France and Germany, and the 2027 speaker panel includes speakers from companies based in Helsinki and Darmstadt.

Is a London event relevant to buyers working under IVDR?

Yes. EU delegates bring IVDR questions, UK delegates work under MHRA rules, and many pharma teams handle both plus FDA. The London 2027 agenda includes Regulation of Companion Diagnostics from a Pharma Perspective, a panel on Regulatory Harmonisation for Biomarker Qualification and a panel on Global CDx Approval Pathways – EMA, FDA & MHRA Perspectives.

When is the event and how does it fit a 2027 budget?

ImmunoMark London runs on 3–4 March 2027. For companies on a calendar financial year, that is early enough for meetings to turn into pipeline and revenue within the same year.

Can we sponsor London and a US edition?

Yes. ImmunoMark also runs San Diego (10–11 February 2027) and Boston (June 2027), both launch editions, and the package structure is the same at every edition. Speak to the team about combining editions.

Do we need to bring a booth from the continent?

Only if you choose a package with exhibition space. Platinum, Gold, Silver and Exhibitor include a 10 x 6 ft space with a table, two chairs and a power outlet. The Exclusive 1:1 Meetings package has no booth, which suits teams flying in with only a laptop.

Biomarker Congress Europe 2027: One Event, UK and EU Buyers

Get the prospectus and package availability